Winter has arrived in most parts of the country, and the mercury has begun to drop. While this season is pleasant for many, ...

The new research, published in ERJ Open Research, found that nearly one in five asthma patients and one in three COPD ...

GINA 2026 no longer endorses a SABA alone for asthma, yet albuterol labels still list only bronchospasm. Airsupra adds exacerbation risk reduction for adults.

The once cheerful Penelope Dunn stopped playing, stopped eating and struggled to catch her breath.

Amneal brings to market a popular asthma controller inhaler as a generic. It sees its beclomethasone device improving patient ...

Even if you don't have major asthma attacks, you may still be bothered by coughing or shortness of breath.For you, there is still room to review your treatment and aim for a state where symptoms are ...

Paediatric asthma as a disease has been recognised since ancient times. In this narrative review, the authors will trace some ...

IMPACT and ETHOS reported fewer deaths with triple therapy, yet neither Trelegy nor Breztri carries that claim, and critics blame ICS withdrawal. Both now treat asthma too.

A narrative review synthesizes real-world evidence supporting single-inhaler triple therapy and the emergence of dupilumab, ...

From hospital visits to missed school days, asthma is taking a lot from Kentuckians. The burden is preventable.

A new review proposes an intelligence-enabled framework that unites smart inhalable biomaterials, machine-learning-driven formulation design, lung-on-chip validation, and patient-specific pulmonary ...

The long, tremendously hot summer is finally over. The mornings are crisp, the evenings are drawing in - and if I hadn't ...